"Our research facility has been conducting Phase II, III and IV pharmaceutical and device clinical trials for major pharmaceutical companies since 2004. These trials, through Visions, provide an opportunity for qualifying individuals to safely participate in research that may lead to more effective medical treatments worldwide. In addition, participants may be eligible for study-related examinations and procedures at no cost."

During the past decade, Visions Clinical Research-Tucson conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 16 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Visions Clinical Research-Tucson" #1 sponsor was "Bayer" with 4 trials, followed by "TherapeuticsMD" with 3 trials sponsored, "Warner Chilcott" with 3 trials sponsored, "Abbott Nutrition" with 2 trials sponsored and "Astellas Pharma Global Development, Inc." with 2 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Visions Clinical Research-Tucson" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Clinical Research Management, Inc." with 1 trials as a collaborator, "Danone Institute International" with 1 trials as a collaborator, "Daré Bioscience, Inc." with 1 trials as a collaborator and "Novum Pharmaceutical Research Services" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Visions Clinical Research-Tucson" are "Cervical Intraepithelial Neoplasia" (3 trials), "Contraception" (3 trials), "Human Papillomavirus" (3 trials), "Menopause" (3 trials) and "Vulvovaginal Atrophy" (3 trials). Many other conditions were trialed in "Visions Clinical Research-Tucson" in a lesser frequency.

Most popular intervention types in "Visions Clinical Research-Tucson" are "Drug" (31 trials), "Device" (7 trials), "Biological" (6 trials), "Other" (5 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "placebo" (3 trials), "Colposcopy" (2 trials), "Control Infant Formula" (2 trials) and "Dapagliflozin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Visions Clinical Research-Tucson" are 31 trials for "Female" genders and 16 trials for "All" genders.

Currently, there are NaN active trials in "Visions Clinical Research-Tucson". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Visions Clinical Research-Tucson, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Visions Clinical Research-Tucson, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".